About Altos Labs
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Headquarters
Altos Labs, San Francisco
Founded
2021-04-15
Industry
Biopharma, Biotechnology, Health Care, Health Diagnostics, Medical
Last Funding Type
Series A
Valuation
3
Total Funding
$3.00 billion dollars
IPO Status
Private
Financial
Altos Labs may be growing as it has attracted significant investment from a venture capitalist who has put hundreds of millions into the company, indicating strong financial backing and investor confidence. This level of funding can support research and development efforts in the biotech field, which is essential for a company specializing in cellular rejuvenation programming. The investment is aimed at advancing the company's work on rejuvenating cells and combating disease, which could lead to breakthroughs and potential new treatments in the healthcare industry.
Altos Labs' Co-founder and Chief Scientist discussed the success of Yamanaka factors in rejuvenation research at the Aspen Ideas Health Conference. Additionally, the president and co-founder of Altos Labs has stepped down from the board of directors of Agilent Technologies.
Altos Labs' Co-founder and Chief Scientist discussed the success of Yamanaka factors in rejuvenation research at the Aspen Ideas Health Conference. Additionally, the president and co-founder of Altos Labs has stepped down from the board of directors of Agilent Technologies.
Funding Rounds
1
Total Funding Amount
$3.00 billion dollars
Number of Investors
1